Proteins: mAb, bsAb, fusion protein and recombinant protein;  

Both E.coli and mammalian expression system (CHO);  

CHO cell titer achieved 39 g/L in IFB;  

Difficult to express protein platforms to tackle issues with tough protein expression.

Operated in full compliance with FDA, EMA, and NMPA quality standards;  

Successfully passed over 50 domestic and international client audits;  

From DNA to IND in 9 months (fast track), biosimilar usually 24-26 months  

Enabled IND submissions for 30+ global clients.  

3 core sites in China and 1 site  in Germany, creating business  flexibilities and allow QP  release in EU;  

100+ global customers;  

Cost effective service modules: less than 50% cost of EU peers